This rule will implement new provisions in the law regarding pain-management clinic controlled substance prescriptions.

DEPARTMENT OF HEALTH
Division of Medical Quality Assurance

Rule No.: RULE TITLE
64B-7.003: Counterfeit-Resistant Prescription Blanks
PURPOSE AND EFFECT: This rule will implement new provisions in the law regarding pain-management clinic controlled substance prescriptions.
SUBJECT AREA TO BE ADDRESSED: Counterfeit-Resistant Prescription Blanks.
SPECIFIC AUTHORITY: 456.004, 456.079, 458.3265(4), 459.0137(4) FS.
LAW IMPLEMENTED: 456.0635, 459.0137, 893.065 FS.
IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE WEEKLY.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Larry McPherson, Executive Director, Division of Medical Quality Assurance, 4052 Bald Cypress Way, Bin #C03, Tallahassee, Florida 32399-3253

THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS NOT AVAILABLE.